A Peek Into The Markets: US Stock Futures Mostly Flat; All Eyes On Jobs Report - Apple (NASDAQ:AAPL), Dropbox (NASDAQ:DBX)

Pre-open movers

U.S. stock futures traded mostly flat in early pre-market trade ahead of nonfarm payrolls data. Investors are awaiting earnings results from Lear Corporation (NYSE:LEA) Goodyear Tire & Rubber Co (NASDAQ:GT), Fluor Corporation (NYSE:FLR) and Spectrum Brands Holdings, Inc. (NYSE:SPB).

US jobs report for July is scheduled for release at 8:30 a.m. ET. Analysts expect nonfarm payrolls rising 900,000 in July following a better-than-expected rise of 850,000 in the previous month. The unemployment rate is expected to decline to 5.7% from 5.9%. Data on wholesale inventories for June will be released at 10:00 a.m. ET, while data on consumer credit for June will be released at 3:00 p.m. ET.

Futures for the Dow Jones Industrial Average gained 5 points to 34,948.00 while the Standard & Poor’s 500 index futures rose 0.75 points to 4,422.25. Futures for the Nasdaq 100 index fell 13 points to 15,154.75.

The U.S. has the highest number of COVID-19 cases and deaths in the world, with total infections in the country exceeding 35,440,480 with around 615,320 deaths. India reported a total of at least 31,856,750 confirmed cases, while Brazil confirmed over 20,066,580 cases.

Oil prices traded higher as Brent crude futures rose 0.5% to trade at $71.61 per barrel, while US WTI crude futures rose 0.4% to trade at $69.37 a barrel. The Baker Hughes North American rig count report for the latest week is scheduled for release at 1:00 p.m. ET.

A Peek Into Global Markets

European markets were mostly lower today. The Spanish Ibex Index fell 0.4% and STOXX Europe 600 Index declined 0.2%. The French CAC 40 Index fell 0.2%, London’s FTSE 100 fell 0.2% while German DAX 30 gained 0.1%. Payroll employment in the French private sector increased 1.2% to 19.75 million in the second quarter, while current account deficit shrank to EUR 0.5 billion in June. Germany's industrial production dropped 1.3% in June, while house prices in the UK rose 7.6% year-over-year in July. Spain's industrial production growth dropped to 11.1% year-over-year in June versus a revised 25.0% growth in the prior month.

Broker Recommendation

Piper Sandler downgraded Moderna, Inc. (NASDAQ:MRNA) from Overweight to Neutral and raised the price target from $246 to $445.

Moderna shares fell 1.8% to $408.66 in pre-market trading.

Check out other major ratings here

Breaking News

Check out other breaking news here

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.

Pre-open movers

A Peek Into Global Markets

Asian markets traded mixed today. Japan’s Nikkei 225 rose 0.33%, Hong Kong’s Hang Seng Index fell 0.10%, while China’s Shanghai Composite Index fell 0.24%. Australia’s S&P/ASX 200 rose 0.5% and India’s BSE Sensex fell 0.3%. The index of leading economic indicators in Japan climbed to 104.1 in June from a final reading of 102.6 in the earlier month, while the index of coincident economic indicators surged to 94.2 from May’s reading of 92.1. Japan’s household spending fell by 5.1% year-over-year in June, while average cash earnings slipped by 0.1% annually in June. The Reserve Bank of India held its benchmark repo rate at 4% at its August meeting.

Broker Recommendation

Piper Sandler downgraded Moderna, Inc. (NASDAQ:MRNA) from Overweight to Neutral and raised the price target from $246 to $445.

Moderna shares fell 1.8% to $408.66 in pre-market trading.

Check out other major ratings here

Breaking News

Dropbox Inc (NASDAQ:DBX) posted stronger-than-expected results for its second quarter on Thursday.
Yelp Inc (NYSE:YELP) reported a surprise profit for its second quarter, while sales exceeded estimates. The company also raised its FY21 sales guidance.
Apple Inc (NASDAQ:AAPL) supplier Hon Hai Precision Industry Co., Ltd (OTC:HNHAF), also known as Foxconn, said Thursday that it was buying a semiconductors plant from Macronix International in a deal worth $91 billion..
Novavax, Inc. (NASDAQ:NVAX) reported that it will delay its submission for an emergency use authorization with the U.S. Food and Drug Administration to the fourth quarter of 2021. The company also reported a wider-than-expected loss for its second quarter.